000			03884nam a22002657a 4500
001			20241102123023.0
003			OCoLC
005			20241102123341.0
008			241102b |||||||| |||| 00| 0 eng d
020			_a978-3-031-59340-6
020			_a978-3-031-59341-3 (eBook)
040			_cddc
041			_aEnglish
100			_qEgesta Lopci
222			_a11C]MET PET adjuvant amino acid amino acid PET analysis assessment astrocytomas bevacizumab biomarkers brain tumors cells chemotherapy Clin Oncol clinical trial cognitive detection diagnosis differentiation diffusion disease DNA dose efficacy EGFR enhancement evaluation everolimus F Fig functional G Galldiks GBM GBM patients glio glioblas glioblastoma multiforme glioma patients grade glioma H high-grade glioma HRQOL https://doi hypofractionated IDH IDH-mutant IDH1 inhibitors Int J Radiat Intraoperative lesions lomustine low-grade gliomas magnetic resonance imaging malignant glioma meningioma meta-analysis metabolic methylation Mol Imaging molecular MRI mutation Neuro Oncol Neuro-Oncology neuronavigation Neurosurg newly diagnosed glioblastoma Nucl Med Mol oligodendroglioma Oncol Biol Phys outcomes overall survival particle therapy patients with glioblastoma pediatric perfusion PET imaging PET/CT phase III trial positron emission tomography potential prognostic proton therapy Radiat Oncol Biol radiation therapy radiomics radiotherapy receptor recurrent glioblastoma Regorafenib resection role RT surgery surgical systematic review techniques temozolomide tion tissue tive TMZ toma tomography tracers treatment uptake
245			_aAdvanced Imaging and Therapy in Neuro-Oncology.
260			_aNuclear Medicine Unit IRCCS-Humanitas Research Hospital Rozzano, Milano, Italy | _b Springer Nature Switzerland AG | _c 2024
300			_a190 Pages
300			_aIncludes References
520			_aZusammenfassung: This book covers all diagnostic and therapeutic aspects of neuro-oncological diseases. In the last decade, the management of brain tumors has been revolutionized following the new WHO classification and thanks to the introduction of molecular markers into the clinical routine. From an imaging point of view, the continuous technological developments and the implementation of various radiopharmaceuticals have paved the way to new clinical indications and has helped optimize patient management. In this context, a major breakthrough could derive from the introduction of radiomics and artificial intelligence in the diagnostic and therapeutic pathway. Not forgetting the emerging role of heavy-ion therapy as a complement to the innovative drugs and treatments adopted in medical oncology and radiation therapy. In the present book, all above-mentioned aspects are covered, starting with the novel standards for the WHO classification of brain tumors, to the up-to-date surgical techniques and advanced therapeutic approaches, passing through the currently available imaging modalities and ongoing developments embracing both radiology and nuclear medicine discipline. Imaging represents indeed the "trait d'union" for all the arguments described in the book; therefore, in most chapters there are dedicated sessions focused on the role of imaging in each specific context. The publication aims to fill the gap between the clinicians and all professionals directly involved in the management of patients with brain tumors and the newest scientific outreach. Moreover, thanks to the comprehensive insight into the latest technological developments, scientists and researchers interested in the topic will find the book a useful tool for future studies and perspective discoveries
600			_xBrain -- Cancer -- Imaging -- Treatment, Cancer -- Treatment.
700			_qLuigi Mansi
856			_uhttps://doi.org/10.1007/978-3-031-59341-3
942			_2ddc _cEB _n0
999			_c29564 _d29564